Expression of antimicrobial peptides such as LL-37 and hBD-2 in nonlesional skin of atopic individuals

Pediatric Dermatology

Volumn 27, Issue 4, 2010, Pages 341-348

  Goo, Jawoong ^a   Ji, Jae Hong ^a   Jeon, Hyerin ^a   Kim, Min Jung ^a   Jeon, Soo Young ^b   Cho, Mee Yon ^c   Lee, Seung Hun ^d   Choi, Eung Ho ^a  

^a Yonsei University Wonju   (South Korea)

^b Konyang University College of Medicine   (South Korea)

^c Yonsei University Wonju College of Medicine   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; INTERLEUKIN 1ALPHA;

ADOLESCENT; ARTICLE; ATOPY; CLINICAL ARTICLE; ELECTRON MICROSCOPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAMELLAR BODY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADOLESCENT; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CHILD; DERMATITIS, ATOPIC; FORESKIN; HUMANS; INTERLEUKIN-1ALPHA; MALE; SKIN;

EID: 77954824600     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2010.01122.x     Document Type: Article

References (44)

1. Harder J, Bartels J, Christophers E et al. A peptide antibiotic from human skin. Nature 1997 387 : 861.
2. Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002 347 : 1151.
3. de Jongh GJ, Zeeuwen P, Kucharekova M et al. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 2005 125 : 1163 1173.
4. Arikawa J, Ishibashi M, Kawashima M et al. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol 2002 119 : 433 439.
5. Chen L, Martinez O, Overbergh L et al. Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin Exp Immunol 2004 138 : 375 387.
6. Watanabe M, Tagami H, Horii I et al. Functional analyses of the superficial stratum corneum in atopic xerosis. Arch Dermatol 1991 127 : 1689 1692.
7. De Benedetto A, Agnihothri R, McGirt LY et al. Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol 2009 129 : 14 30.
8. Lin YT, Wang CT, Chiang BL. Role of bacterial pathogens in atopic dermatitis. Clin Rev Allergy Immunol 2007 33 : 167 177.
9. Braff MH, Di Nardo A, Gallo RL. Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies. J Invest Dermatol 2005 124 : 394 400.
10. Huh WK, Oono T, Shirafuji Y et al. Dynamic alteration of human β-defensin 2 localization from cytoplasm to intercellular space in psoriatic skin. J Mol Med 2002 80 : 678 684.
11. Oren A, Ganz T, Liu L et al. In human epidermis, β-defensin 2 is packaged in lamellar bodies. Exp Mol Pathol 2003 74 : 180 182.
12. Ali RS, Falconer A, Ikram M et al. Expression of the peptide antibiotics human b defensin-1 and human b defensin-2 in normal human skin. J Invest Dermatol 2001 117 : 106 111.
13. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002 415 : 389 395.
14. Harder J, Meyer-Hoffert U, Wehkamp K et al. Differential gene induction of human beta-defensins(hBD-1,-2,-3, and 4) in keratinocytes is inhibited by retinoic acid. J Invest Dermatol 2004 123 : 522 529.
15. Liu AY, Destoumieux D, Wong AV et al. Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol 2002 118 : 275 281.
16. Frohm M, Agerberth B, Ahangari G et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997 272 : 15258 15263.
17. Zaiou M, Nizet V, Gallo RL. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP 18/LL-37) prosequence. J Invest Dermatol 2003 120 : 810 816.
18. Howell MD, Wollenberg A, Gallo RL et al. Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol 2006 117 : 836 841.
19. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980 92 : 44 47.
20. Choi EH, Brown BE, Crumrine D et al. Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. J Invest Dermatol 2005 124 : 587 595.
21. Howell MD, Novak N, Bieber T et al. Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol 2005 125 : 738 745.
22. Ashida Y, Ogo M, Denda M. Epidermal interleukin-1 alpha generation is amplified at low humidity: implications for the pathogenesis of inflammatory dermatoses. Br J Dermatol 2001 144 : 238 243.
23. Elias PM, Choi EH. Interactions among stratum corneum defensive functions. Exp Dermatol 2005 14 : 719 726.
24. Akiyama H, Yeda M, Toi Y et al. Comparison of the severity of atopic dermatitis lesions and the density of Staphylococcus aureus on the lesions after antistaphylococcal treatment. J Infect Chemother 1996 2 : 70 74.
25. Braff MH, Zaiou M, Fierer J et al. Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Infect Immun 2005 73 : 6771 6781.
26. Hancock RE, Scott MG. The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci U S A 2000 97 : 8856 8861.
27. Chung WO, Dale BA. Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species. Infect Immun 2004 72 : 352 358.
28. Sorensen OE, Follin P, Johnsen AH et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001 97 : 3951.
29. Lopez-Garcia B, Lee PHA, Yamasaki K et al. Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J Invest Dermatol 2005 125 : 108 115.
30. Dorschner RA, Pestonjamasp VK, Tamakuwala S et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 2001 117 : 91 97.
31. Murakami M, Ohtake T, Dorschner RA et al. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol 2002 119 : 1090 1095.
32. Liu L, Wang L, Jia HP et al. Structure and mapping of the human β-defensin HBD-2 gene and its expression at sites of inflammation. Gene 1998 222 : 237 244.
33. Debets R. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis. J Immunol 1997 158 : 2955 2963.
34. Mee JB, Cork MJ, di Giovine FS et al. Interleukin-1: a key inflammatory mediator in psoriasis? Cytokine 2006 33 : 72 78.
35. Schmid P, Grenet O, Medina J et al. Letters to the editor an intrinsic antibiotic mechanism in wounds and tissue-engineered skin. J Invest Dermatol 2001 116 : 471.
36. Glaser R, Harder J, Lange H et al. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 2005 6 : 57 64.
37. Fartasch M, Bassukas ID, Diepgen TL. Disturbed extruding mechanisms of lamellar bodies in dry non-eczematous skin of atopics. Br J Dermatol 1992 127 : 221 227.
38. Fartasch M. Epidermal barrier in disorders of the skin. Microsc Res Tech 1997 38 : 361 372.
39. Holleran WM, Man MQ, Gao WN et al. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest 1991 88 : 1338 1345.
40. Mao-Qiang M, Elias PM, Feingold KR. Fatty acids are required for epidermal permeability barrier function. J Clin Invest 1993 92 : 791 798.
41. Menon GK, Feingold KR, Elias PM. Lamellar body secretory response to barrier disruption. J Invest Dermatol 1992 98 : 279 289.
42. Wood LC, Elias PM, Calhoun C et al. Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol 1996 106 : 397 403.
43. Barland CO, Zettersten E, Brown BS et al. Imiquimod-induced interleukin-1 alpha stimulation improves barrier homeostasis in aged murine epidermis. J Invest Dermatol 2004 122 : 330 336.
44. Pastore S, Fanales-Belasio E, Albanesi C et al. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J Clin Invest 1997 99 : 3009 3017.